Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,069
Closed -$206K 202
2024
Q3
$206K Sell
3,069
-95
-3% -$7.8K 0.03% 208
2024
Q2
$359K Sell
3,164
-312
-9% -$39.4K 0.05% 158
2024
Q1
$482K Buy
3,476
+45
+1% +$5.66K 0.07% 143
2023
Q4
$426K Buy
3,431
+261
+8% +$26.7K 0.06% 155
2023
Q3
$296K Buy
3,170
+95
+3% +$10.7K 0.05% 176
2023
Q2
$395K Sell
3,075
-1,452
-32% -$176K 0.06% 141
2023
Q1
$526K Sell
4,527
-629
-12% -$70.4K 0.09% 95
2022
Q4
$584K Buy
5,156
+16
+0.3% +$1.76K 0.11% 90
2022
Q3
$596K Buy
5,140
+160
+3% +$13.6K 0.13% 83
2022
Q2
$371K Buy
4,980
+412
+9% +$37.6K 0.07% 134
2022
Q1
$584K Buy
4,568
+224
+5% +$24.5K 0.09% 92
2021
Q4
$583K Sell
4,344
-400
-8% -$57.5K 0.09% 94
2021
Q3
$649K Buy
4,744
+324
+7% +$40.9K 0.12% 75
2021
Q2
$472K Buy
4,420
+1,144
+35% +$110K 0.09% 107
2021
Q1
$294K Buy
3,276
+384
+13% +$36K 0.06% 149
2020
Q4
$267K Buy
+2,892
New +$258K 0.06% 147

Other funds holding DXCM

Gilbert & Cook's DXCM Position: Q4 2024 in Review

Gilbert & Cook sold out of DexCom (DXCM) in Q4 2024, closing a stake of 3,069 shares — an estimated $206K sold.

Gilbert & Cook first reported a position in DXCM in Q4 2020 and held it in 16 quarters. The position peaked at $649K in Q3 2021. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Gilbert & Cook reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Gilbert & Cook sold 3,069 DexCom shares in Q4 2024, an estimated $206K.
  • Gilbert & Cook first reported a position in DexCom in Q4 2020 and held it in 16 quarters.
  • Gilbert & Cook's DexCom position peaked at $649K in Q3 2021.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Gilbert & Cook's 13F filing for Q4 2024, filed 23 Jan 2025.